Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 47.79M | $71.0M | 6.41% | -- | 2026-06-30 |
| BlackRock, Inc. | 36.98M | $55.0M | 4.96% | +746.7K | 2026-06-30 |
| Vanguard Capital Management LLC | 14.97M | $22.0M | 2.01% | +469.8K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 14.93M | $22.0M | 2.00% | +165.2K | 2026-06-30 |
| Geode Capital Management, LLC | 11.58M | $17.0M | 1.55% | +279.5K | 2026-06-30 |
| State Street Corp | 10.31M | $15.0M | 1.38% | +807.7K | 2026-06-30 |
| Goldman Sachs Group Inc | 7.04M | $10.0M | 0.94% | -639.5K | 2026-06-30 |
| UBS Group AG | 5.01M | $7.0M | 0.67% | -1.07M | 2026-06-30 |
| Whitefort Capital Management, LP | 4.51M | $6.0M | 0.60% | +258.1K | 2026-06-30 |
| Northern Trust Corp | 3.76M | $5.0M | 0.50% | +136.8K | 2026-06-30 |
